We are a specialty vaccine company providing prevention against diseases with major unmet medical needs.

Valneva logo

Our focused pipeline includes the only Lyme disease vaccine candidate in clinical development today, a single-shot chikungunya vaccine candidate, and an inactivated vaccine candidate against COVID-19.

Our strategy stems from our vision to contribute to a world in which no one dies or suffers from a vaccine-preventable disease. We aim to become the leading specialty vaccine company. Our strategy is based on an integrated business model that has a unique risk profile and significant potential for value creation.